top of page

For
better health

Dascoli Umbrella for better health
Driving the supply, distribution and professional training of medical cannabis in Switzerland

OUR PURPOSE

Committed to the therapeutic potential of medical cannabis

Dascoli_Therapy_Medcan.png

We enable healthcare professionals to effectively use medical cannabis as an evidence-based treatment option. So that patients can not only have safe access to medical cannabis, but also rely on expert medical care in this field.

01

Education

02

Wholesale

03

Pharmacy

OUR EXPERTISE

We’ve got it covered – 

whatever you need

Providing in-depth training sessions to physicians, therapists, pharmacists and other healthcare professionals. 

Offering a reliable and stable product supply that meets pharmaceutical GDP/GMP quality standards to the healthcare sector.

Own pharmacy Stauffacher Apotheke in Zurich.

Medical Cannabis Pharmacy
Cover_Pharmactuel_Dascoli Kopie.jpg

Educational journal pharmActuel - Accredited with 25 FPH credits

Publication date: 11/03/2025

Cannabis sativa L. has been officially recognised as a medically legal medicinal plant in Switzerland since 1st of August 2022. Medicines containing THC and CBD can be prescribed by doctors with therapeutic freedom for the corresponding indications and are increasingly becoming a successful treatment option. Phytotherapy has thus regained a new, potent medicinal plant in its repertoire, which is also used in hard indications such as spasticity in multiple sclerosis, neuropathic pain or forms of paediatric epilepsy.

 

The monographs for cannabis flowers of PH HELV 12 CH311 and PH EUR 3028 provided the basis for the development of cannabis extracts and other formulations in the magistral formula area.

Cannabis pharmaceuticals represent a new challenge for pharmacies due to the highly dynamic nature of various stakeholders and demanding patients. At the same time, there are still regulatory hurdles in the implementation and qualitative aspects in the area of raw materials challenge pharmacists in the analytical in the analytical field. This training journal provides you with the knowledge you need to be prepared when you receive a prescription for medicinal cannabis or if you want to specialise your pharmacy accordingly.

Stronger together 

Success is build on partnerships. This is the reason why we want to join forces with suppliers, healthcare professionals, scientific associations and other stakeholders. Together we can strengthen the trust in medical cannabis in Switzerland. 

Dascoli_handshake_medcan_edited.png

OUR MANAGEMENT

Differences make the difference

With our top management we have two people leading, who have been operating and researching in the area of medical cannabis for several years: Andrew Petronanos and Dr. Simon Nicolussi.

Different qualities that complement each other, Andrew and Simon are a team of seasoned professionals and pioneers in the field of medical cannabis.

Andrew Petronanos Dascoli Pharma AG

Andrew D. Petronanos

CEO & Founder

Dr. Simon Nicolussi Dascoli Pharma AG

Dr. Simon Nicolussi

Chief Scientific Officer,

Medical Affairs

bottom of page